Work

Sorafenib in malignant mesothelioma (MM): A phase II trial of the Cancer and Leukemia Group B (CALGB 30307)

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.7707

Authors: P. A. Janne, X. F. Wang, L. M. Krug, L. Hodgson, E. E. Vokes, H. L. Kindler

Institutions: Memorial Sloan Kettering Cancer Center, Duke University, University of Chicago, Dana-Farber Cancer Institute

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2228639901

Cites:

Cited by: 31

Related to: 10